New developments in prostaglandin and thromboxane research: introduction. 1979

J C McGiff

UI MeSH Term Description Entries
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013931 Thromboxanes Physiologically active compounds found in many organs of the body. They are formed in vivo from the prostaglandin endoperoxides and cause platelet aggregation, contraction of arteries, and other biological effects. Thromboxanes are important mediators of the actions of polyunsaturated fatty acids transformed by cyclooxygenase. Thromboxane

Related Publications

J C McGiff
January 1976, Advances in prostaglandin and thromboxane research,
J C McGiff
August 2004, Mini reviews in medicinal chemistry,
J C McGiff
May 2024, Administration and policy in mental health,
J C McGiff
November 1963, American journal of public health and the nation's health,
J C McGiff
December 1992, Clinical chemistry,
J C McGiff
April 1990, Zeitschrift fur Gastroenterologie. Verhandlungsband,
J C McGiff
January 1991, Pharmacology & therapeutics,
J C McGiff
May 2008, Journal of microscopy,
Copied contents to your clipboard!